East Syracuse site to serve as the LOTTE Center for North America Operations for LOTTE’s biologics contract development and manufacturing organization (CDMO) business
Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer
The new facility is scheduled to start operation in the first half of 2024
The plant is scheduled to come on stream in September 2024
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
In his previous assignment Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as Chief Commercial Officer
Subscribe To Our Newsletter & Stay Updated
